Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Authors
Keywords
-
Journal
BMC Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-26
DOI
10.1186/s12916-018-1163-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-422a weakened breast cancer stem cells properties by targeting PLP2
- (2018) Yanmei Zou et al. CANCER BIOLOGY & THERAPY
- MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer
- (2018) Sandra Lettlova et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a
- (2018) Tao Zhang et al. International Journal of Biological Sciences
- MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance
- (2017) Elizabeth C. Martin et al. FEBS LETTERS
- Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer
- (2017) Y. Shen et al. GENETICS AND MOLECULAR RESEARCH
- MicroRNAs in the prognosis of triple-negative breast cancer
- (2017) Lingshuang Lü et al. MEDICINE
- Invasive Breast Cancer: Recognition of Molecular Subtypes
- (2017) Johanna D. Strehl et al. Breast Care
- miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells
- (2016) X-H He et al. ONCOGENE
- Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
- (2016) Xiaodan Meng et al. Oncotarget
- The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance
- (2015) Lei Zhao et al. CANCER LETTERS
- Data Normalization Strategies for MicroRNA Quantification
- (2015) H. Schwarzenbach et al. CLINICAL CHEMISTRY
- The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer
- (2015) Heidi Schwarzenbach EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- miR-365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer
- (2015) MIN LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2
- (2015) Nishi R. Sharma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
- (2015) Isabel Stückrath et al. Oncotarget
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
- (2015) Corinna Eichelser et al. Oncotarget
- Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)†
- (2014) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
- (2014) Annette R. Kodahl et al. Molecular Oncology
- Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF- in Breast Cancer
- (2013) L. Jin et al. CANCER RESEARCH
- Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers
- (2013) Fermín Mar-Aguilar et al. DISEASE MARKERS
- Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling
- (2013) Fei Ma et al. GENE
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
- (2013) Katarina Cuk et al. PLoS One
- The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
- (2012) Saumya Pant et al. BIOCHEMICAL PHARMACOLOGY
- Horizontal transfer of microRNAs: molecular mechanisms and clinical applications
- (2012) Xi Chen et al. Protein & Cell
- Vesicle transfer and cell fusion
- (2011) T. Kevin Howcroft et al. CANCER BIOLOGY & THERAPY
- MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
- (2011) W. Shi et al. CANCER RESEARCH
- Characterization of extracellular circulating microRNA
- (2011) Andrey Turchinovich et al. NUCLEIC ACIDS RESEARCH
- miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg
- (2011) Mayuko Yamamoto et al. PLoS One
- Haemolysis during Sample Preparation Alters microRNA Content of Plasma
- (2011) Michaela B. Kirschner et al. PLoS One
- Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’
- (2011) Tae Hoon Lee et al. Seminars in Immunopathology
- MicroRNA-155Regulates Cell Survival, Growth, and Chemosensitivity by TargetingFOXO3ain Breast Cancer
- (2010) William Kong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Exosomes: proteomic insights and diagnostic potential
- (2009) Richard J Simpson et al. Expert Review of Proteomics
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started